Skip to main content

Paromomycin Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Mar 27, 2023.

Paromomycin is also known as: Humatin, Paromycin

Paromomycin Pregnancy Warnings

The manufacturer makes no recommendation regarding use during pregnancy.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: Not formally assigned to a pregnancy category.

-This drug is poorly absorbed after oral administration, with almost 100% of the drug recoverable in feces; little drug would be available to reach the fetus.

Animal studies have not been reported. There are no controlled data in human pregnancy.

In 1 report, 2 women were treated with this drug for 10 days for symptomatic Giardia infections during the 10th and 20th week of pregnancy. No congenital malformations or fetal toxicity were reported.

See references

Paromomycin Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

-No data available on the clinical use of this drug during breastfeeding.
-This drug is poorly absorbed orally; it is not likely to reach the bloodstream of the infant or cause any harmful effects in nursing infants.

See references

References for pregnancy information

  1. Kreutner AK, Del Bene VE, Amstey MS "Giardiasis in pregnancy." Am J Obstet Gynecol 140 (1981): 895-901
  2. "Product Information. Humatin (paromomycin)." Parke-Davis (2001):
  3. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online]" (2015):

References for breastfeeding information

  1. "Product Information. Humatin (paromomycin)." Parke-Davis (2001):
  2. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online]" (2015):
  3. National Library of Medicine (US) "Drugs and Lactation Database (LactMed)" (2019):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.